$MGLN MAGELLAN HEALTH INC Insider Trading Week 37/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MAGELLAN HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MAGELLAN HEALTH INC in week 37/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 585 | 35,422 | 40,426 | |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 19 | 1,150 | 41,011 | |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 83.00 | 585 | 48,555 | 0 | 585 to 0 (-100.00 %) |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 585 | 35,422 | 585 | 0 to 585 |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 83.00 | 19 | 1,577 | 0 | 19 to 0 (-100.00 %) |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 19 | 1,150 | 19 | 0 to 19 |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 53.00 | 14,096 | 747,088 | 20,465 | |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 83.06 | 14,096 | 1,170,883 | 13,457 | 27.6 K to 13.5 K (-51.16 %) |
Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 53.00 | 14,096 | 747,088 | 27,553 | 13.5 K to 27.6 K (+104.75 %) |
Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 670 | 40,569 | 41,030 | |
Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 83.00 | 670 | 55,610 | 0 | 670 to 0 (-100.00 %) |
Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 670 | 40,569 | 670 | 0 to 670 |
Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 53.00 | 2,400 | 127,200 | 34,561 | |
Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 83.00 | 2,400 | 199,200 | 13,457 | 15.9 K to 13.5 K (-15.14 %) |
Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 53.00 | 2,400 | 127,200 | 15,857 | 13.5 K to 15.9 K (+17.83 %) |
Sep 11 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 6,267 | 379,467 | 41,700 | |
Sep 11 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 81.53 | 6,267 | 510,918 | 0 | 6.3 K to 0 (-100.00 %) |
Sep 11 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 6,267 | 379,467 | 6,267 | 0 to 6.3 K |